United States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
February 3, 2025 (January 28, 2025)
Date of Report (Date of earliest event reported)
FG Merger II Corp.
(Exact Name of Registrant as Specified in its Charter)
| Nevada | 001-42493 | 86-2579471 | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
104 S. Walnut Street, Unit 1A, Itasca, IL | 60143 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (847) 773-1665
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| Common Stock | FGMC | THE NASDAQ STOCK MARKET LLC | ||
| Rights | FGMCR | THE NASDAQ STOCK MARKET LLC | ||
| Units | FGMCU | THE NASDAQ STOCK MARKET LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 1.01. Entry into a Material Definitive Agreement.
On January 30, 2025, FG Merger II Corp. (the “Company”) consummated its initial public offering (the “IPO”) of 8,000,000 units (the “Units”). Each Unit consists of one share of common stock of the Company, par value $0.0001 per share (the “Common Stock”), and one right to receive one-tenth (1/10) of a share of Common Stock upon the consummation of an initial business combination. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $80,000,000. The Company granted the underwriters a 45-day option to purchase up to 1,200,000 additional Units to cover over-allotments, if any.
Of the net proceeds of the IPO, including the exercise of the over-allotment option, and the sale of the Private Placement Securities (as defined below), $80,800,000 has been deposited into a U.S. based trust account at J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company acting as trustee. Except with respect to interest earned on the funds held in the trust account that may be released to the Company (i) to pay its franchise and income tax obligations and (ii) for working capital purposes (not to exceed $1,000,000 annually), the proceeds from the IPO and the sale of the Private Placement Securities held in the trust account will not be released from the trust account until the earliest to occur of (a) the completion of the Company’s initial business combination (including the release of funds to pay any amounts due to any public stockholders who properly exercise their redemption rights in connection therewith), (b) the redemption of any public shares properly submitted in connection with a stockholder vote to approve an amendment to the Articles of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of the Company’s public shares if the Company does not complete an initial business combination within 24 months from the closing of the IPO or (c) the redemption of the Company’s public shares if the Company is unable to complete its business combination within 24 months from the closing of the IPO, subject to applicable law.
In connection with the IPO, the Company entered into the following agreements, the terms of which were previously described in the Company’s Registration Statement on Form S-1 (File No. 333- 275155) related to the IPO, originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on January 21, 2025 (as amended, the “Registration Statement”):
| · | An Underwriting Agreement, dated January 28, 2025 by and between the Company and ThinkEquity LLC, as representative of the several underwriters, a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference. |
| · | A Warrant Agreement, dated January 30, 2025 (the “Warrant Agreement”), by and between the Company and Continental Stock Transfer & Trust Company, LLC, as warrant agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference. | |
| · | A Letter Agreement, dated January 28, 2025, by and among the Company and its officers, directors, FG Merger Investors II LLC (the “Sponsor”) and Ramnarain Joseph Jaigobind, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference. | |
| · | An Investment Management Trust Agreement, dated January 28, 2025, by and between the Company and Continental Stock Transfer & Trust Company, LLC, as trustee, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference. | |
| · | A Registration Rights Agreement, dated January 28, 2025, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference. | |
| · | An Administrative Services Agreement , dated January 28, 2025, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 and incorporated herein by reference. | |
| · | Indemnity Agreements, dated as of January 28, 2025, by and between the Company and each of the officers and directors of the Company, copies of which are attached as Exhibit 10.5 and incorporated herein by reference. | |
| · | A Private Placement Units Purchase Agreement, dated January 28, 2025, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.6 and incorporated herein by reference. | |
| · | A $15 Exercise Price Warrants Purchase Agreement, dated January 28, 2025, between the Registrant and FG Merger Investors LLC, a copy of which is attached as Exhibit 10.7 and incorporated herein by reference. | |
| · | A Private Placement Units Purchase Agreement, dated January 28, 2025, by and between the Company and Ramnarain Joseph Jaigobind, a copy of which is attached as Exhibit 10.8 and incorporated herein by reference. |
| · | Promissory Note issued to FG Merger Investors II LLC, a copy of which is attached as Exhibit 10.8 and incorporated herein by reference. | |
| · | Rights Agreement, dated January 28, 2025, by and between FG Merger II Corp. and Continental Stock Transfer & Trust Company, a copy of which is attached as Exhibit 10.9 and incorporated herein by reference. |
Item 3.02. Unregistered Sales of Equity Securities.
Simultaneously with the closing of the IPO, the Company consummated private placements (the “Private Placements”) in which (i) the Sponsor and Ramnarain Joseph Jaigobind, the Chief Executive Officer of ThinkEquity LLC, purchased 223,300 units and 25,000 units (collectively, the “Private Units”) at a price of $10.00 per Private Unit, and (ii) the Sponsor purchased 1,000,000 warrants (“$15 Exercise Price Warrants” and, together with the Private Units, the “Private Placement Securities”) at a price of $0.10 per warrant, each exercisable to purchase one share of Common Stock at $15.00 per share, for an aggregate purchase price of $2,583,000.
The Private Units are otherwise identical to the Units sold in the IPO, except that the Private Units are subject to transfer restrictions. Each $15 Exercise Price Warrant entitles the registered holder to purchase one share of Common Stock at a price of $15.00 per share at any time commencing on the later of 12 months from the closing of the IPO and 30 days after the completion of the Company’s initial business combination, provided the terms set forth in the Warrant Agreement are satisfied. The $15 Exercise Price Warrants are non-redeemable and may be exercised on a cashless basis. The Private Placement Securities may not, subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the Company’s initial business combination. The Sponsor was granted certain demand and piggyback registration rights in connection with the purchase of the Private Placement Securities.
The Private Placement Securities were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, as the transactions did not involve a public offering.
As of January 30, 2025, a total of $80,800,000 of the net proceeds from the IPO and the Private Placements were deposited in a trust account established for the benefit of the Company’s public stockholders.
Item 5.03. Amendments to Certificate of Incorporation or Bylaws
On January 28, 2025, in connection with the IPO, the Company filed its Amended and Restated Articles of Incorporation with the Nevada Secretary of State. The terms of the Amended and Restated Articles of Incorporation are set forth in the Registration Statement and are incorporated herein by reference. A copy of the Company’s Amended and Restated Articles of Incorporation is attached as Exhibit 3.1 hereto, and is incorporated by reference herein.
Item 7.01 Other Events.
On January 28, 2025, the Company issued the press release attached hereto as Exhibit 99.1, announcing the pricing of the IPO.
On January 30, 2025, the Company issued the press release attached hereto as Exhibit 99.2, announcing the closing of the IPO.
The information in this Item 7.01 (including the exhibits) shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing under the Securities Act or the Exchange Act. On February 3, 2025, the Company issued the press release attached hereto as Exhibit 99.2, announcing closing of fully-exercised over-allotment option in connection with its IPO.
Item 9.01. Financial Statements and Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: February 3, 2025
FG MERGER II CORP.
| By: | /s/ Hassan R. Baqar | ||
| Name: | Hassan R. Baqar | ||
| Title: | Chief Financial Officer |
